Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease

BACKGROUND: Cerebrospinal fluid (CSF) levels of monoamine metabolites may represent biomarkers of Parkinson's disease (PD). OBJECTIVE: The aim of this study was quantification of multiple metabolites in CSF from PD versus healthy control subjects (HCs), including longitudinal analysis. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kremer, Thomas, Taylor, Kirsten I., Siebourg‐Polster, Juliane, Gerken, Thomas, Staempfli, Andreas, Czech, Christian, Dukart, Juergen, Galasko, Douglas, Foroud, Tatiana, Chahine, Lana M., Coffey, Christopher S., Simuni, Tanya, Weintraub, Daniel, Seibyl, John, Poston, Kathleen L., Toga, Arthur W., Tanner, Caroline M., Marek, Kenneth, Hutten, Samantha J., Dziadek, Sebastian, Trenkwalder, Claudia, Pagano, Gennaro, Mollenhauer, Brit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453505/
https://www.ncbi.nlm.nih.gov/pubmed/33942926
http://dx.doi.org/10.1002/mds.28608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453505/
https://www.ncbi.nlm.nih.gov/pubmed/33942926
http://dx.doi.org/10.1002/mds.28608

Ejemplares similares